INTRODUCTION
Purification of individual complement components has been important for study of their biological activities. Production of monospecific antisera has allowed a Received for publication 1 October 1970. practical means of measuring complement protein concentrations clinically and has been useful for associating specific proteins with biologic activity (1-3). Antisera have not been described for Cir, C7, and C9.1 This report describes a method to obtain Cir, a subunit of C1, in a highly purified state.
Cl is the first complement component to combine with antigen-antibody complexes. After this association, C1 is activated from its proenzymatic state (4) . Activated C1, C1, reacts enzymatically with C4 and C2 to form the second enzyme in the complement sequence, C42, which is capable of cleaving C3 efficiently to produce a capillary permeability factor and chemotactic factor, C3a (5) . A C-derived kinin is also produced in association with-the activation of these initially reacting enzymes of the complement sequence (6) . Understanding the early events in C activation is important as there is evidence that C1 has been activated in systemic lupus erythematosus, acute glomerulonephritis, rheumatoid arthritis, hereditary angioedema, and other miscellaneous diseases. In 1963 Lepow, Naff, Todd, Pensky, and Hinz discovered that human C1 was a macromolecule composed I The symbols for complement components used in this paper conform to recommendations agreed upon by a committee sponsored by the World Health Organization. Nomenclature of Complement. 1970. Immunochemistry 7: 137. Complement (C) components are designated numerically C1, C2, C3, C4, C5, C6, C7, C8, C9; the subunits of C1 are designated Clq, Clr, Cls; activated components are indicated by placing a bar over the numeral which refers to the active component or subunit; i.e., active C1 = CY; active Cls = Cis; convertase = C42, etc. Since guinea pig components were used except for the C1 subunits which were always from human serum, a superscript indicating the species will be omitted. Cellular intermediates carrying C components are designated EAC . . . followed by the numeral designating the components carried; e.g., EAC14. Donaldson (10) , and the hypothesis that CIr is an enzyme which activates Cls has been proposed (11) . All previous published work on CIr has been performed with relatively crude CIr fractions from a single DEAE-cellulose purification step after euglobulin precipitation. As Cls is chromatographically and electrophoretically heterogeneous (12) and overlaps CIr in its elution pattern from DEAE-cellulose, these studies were done to obtain highly purified Cir.
In addition to purification, a quantitative assay is presented using Borsos and Rapp's method for measurement of purified macromolecular C1. There is good evidence that absolute molecular concentrations of C! can be determined (13) . Our assay determines the number of C! molecules formed when CIr is combined with Clq and Cls. This combination step is similar to the first step in the hemolytic assay described by Lepow et al. (7) . We modified that assay in order to use the quantitative Cl assay and to distinguish activated CIs from macromolecular C1. The assay described in this paper discriminates between the hemolytic function of C1 and that of Cis by the capacity of CI molecules to bind to EAC4 cells. Cis molecules do not bind and can be washed away (14) .
Using this assay we have studied the effect of buffers and temperature on the stability of CIr and designed a purification process taking advantage of conditions for maximal stability. Thus a highly purified preparation of CIr and a sensitive assay method are now available and the biological functions of Clr can be further explored in clinical states such as the isolated Cir deficiency discussed by Pickering, Naff, Stroud, Good, and Gewurz (15) in a patient with glomerulonephritis. Also studies of Stroud et al. (2) have shown that the C1 subunits, Clq and Cls, may exist in markedly disparate concentrations. These observations suggest that the synthesis and/or metabolism of these subunits is regulated by independent mechanisms and that their function may be independent.
We anticipate that these methods will serve for the development of monospecific antisera to measure CIr immunochemically and will stimulate further study of these questions.
METHODS
Buffers. The resistance of buffers at 00C was referred to a standard curve obtained with various molarities of NaCl. The value obtained is expressed as the relative salt concentration (RSC). Veronal buffered saline containing gelatin, Ca++, and Mg++, RSC' 0.147 (VBS++) was prepared according to Mayer (16) . VBS is the same buffer without gelatin, Ca++, or Mg++. Dextrose Veronal buffered saline (DGVBS++), RSC 0.065, was prepared by mixing 4 volumes of VBS++ and 6 volumes of 5% dextrose. Both solutions contained 1.0 X 10-3 M Mg++, 1.5 X 10-4 M Ca++, and 0.1 g/100 ml gelatin. EDTA buffer was prepared by mixing 9 volumes of VBS with 1 volume of 0.1 M EDTA at pH 7.4. Buffers at different pH values were made by adding NaCl to a final concentration of 0.02 or 0.15 M to 0.005 M sodium acetate pH 5.0; 0.005 M sodium phosphate pH 6.0, 7.0, and 7.5; or 0.005 M Tris-HCl buffers pH 8.3 and 9.0. The pH of these buffers was measured at the temperature at which they were used.
Complement components. Cl preparations were obtained by the procedure of Tamura and Nelson (17) abbreviated to a single precipitation. Clq was prepared using the method of Muller-Eberhard (18) and stored at 00C, pH 5.0, 0.75 RSC phosphate buffer, at a concentration of 990 ,ug/ml. Highly purified Cis was obtained by the method of Nagaki and Stroud (14) using preparative acrylamide electrophoresis instead of Pevikon electrophoresis (12) . Guinea pig C2 was prepared by the method of Nelson, Jensen, Gigli, and Tamura (19) . Fresh guinea pig serum (Texas Biological, Fort Worth, Tex.) diluted 1/50 in EDTA buffer (C-EDTA) was used as the source of C3-9.
Some of the CIr preparations referred to as "crude CIr" were obtained as by-products of Cls purification after CMand DEAE-cellulose chromatography. Clr passed through CM cellulose at pH 5.0, RSC 0.1 together with Cls. CIr eluted from DEAE-cellulose before Cls at a RSC of 0.170 with 0.05 M sodium phosphate buffer at pH 7.5, 0.01 M EDTA. Such preparations are contaminated with C4, C3, IgG, and traces of Cls, but do not contain Clq. Crude and purified CIr samples were stored at 0°C or -70°C in EDTA buffer or VBS.
C component titrations. C1 was titrated using EAC4 as described by Borsos and Rapp (13) . When it was necessary to eliminate the unbound Cis, the EAC14 cells were washed twice with DGVBS++. Cis was assayed hemolytically as described (14) . The Clr hemolytic activity was assayed combining CIr with Clq and Cis and then reacting the C1 formed with EAC4, C2, and C-EDTA as will be described in detail below. A C1 site-forming unit (C1 SFU) of Clr refers to the amount of CIr which, when added to a specific amount of Clq and Cls, produces 1.5 X 108 effective molecules of C1. The useful concept of a site-forming unit (SFU) is based on the one hit theory of complement activity, and was first applied to C2 (20) . It is the amount of a component producing one effective hemolytic site per cell in a system that contains 1.5 X 108 cells/ml. C2 was titrated using the method of Borsos, Rapp, and Mayer (20) .
Radial immunodiffusion. Cls was assayed by radial immunodiffusion as described (12) . Clq content was determined using monospecific antisera prepared by the method of Yonemasu and Stroud,3 using a modification of the method of Mancini, Carbonara, and Heremans (21 Nonlinear gradients were used for the elution of the protein fractions, and details of the procedure will be described below.
Disc acrylamide electrophoresis. The method of Davis was used for analytic disc electrophoresis (23) . Following the electrophoretic run the gels were fixed 1 hr in 10% trichloracetic acid (TCA) and stained overnight with 0.1% Coomassie Brilliant Blue dye in 10% TCA. Residual dye was removed by repeated washes with 10% TCA. Studies of the sensitivity of this method showed that it was possible to detect 0.005 mg of human serum albumin.
Preparative acrylamide electrophoresis was done at 4°C using gel columns of 1.3 cm diameter, 5 cm running gel height, 1.5 cm stacking gel height, and the same buffers and gel solutions as for analytical runs.
Samples with an absorbance of 0.100-0.300. ODxo U/ml4 and 5% sucrose were applied in volumes of 0.5-1.0 ml on the top of the stacking gel. 2.5% sucrose in running buffer was carefully overlayered to stabilize the sample zone.
Overnight runs for preparation of Clr were performed at 100 v in the cold room at 4°C for 15 hr. The gels were sliced in 2 mm segments and eluted with 0.15 M NaCl at 0°C. All buffers and gels were precooled before the application of CIr to avoid losses of activity.
RESULTS
Stability of Clr. Attempts to purify CIr beyond the initial chromatographic step described by Lepow et al. (7) were difficult due to the instability of this component under certain conditions. Using crude CIr preparations obtained after CMcellulose and DEAE-cellulose chromatography of C1 as a by product of Cls purification, a preliminary study on the stability of crude CIr was made. Dilutions of crude CIr containing 200 CI SFU/ml were incubated at 0°C or at 25°C for 24 hr at various ionic strengths and pH 7.5 as shown in Table I . After incubation the preparations were diluted and the residual Clr activity was assayed by adding Clq and Cis as described below.
The results indicate that some activity was lost even at 0°C when compared to the control sample diluted from the stock CIr solution in DGVBS++ and assayed without incubation. However, there was a greater loss of activity in the samples that were held at room temperature. 95% of the original activity was lost in the 40ne optical density unit at 280 mu (OD28o U) is the optical density of a solution at 280 mju in a 1 cm light path cuvette. sample diluted in 0.015 RSC pH 7.4 buffer and held at room temperature for 24 hr. The effect of pH variation was explored at 0.02 RSC or 0.15 RSC using the buffers described above. As shown in Table II , portions of Clr containing 36.0 C! SFU/ml of CIr were incubated at 370 or 0C for 1 hr in these buffers. The residual CIr activity was determined after a sufficiently high dilution of the CIr samples in DGVBS++ to adjust the pH to 7.4 and the RSC to 0.065. It was found that there was a sharp decrease in activity when the samples were incubated at pH 7-8 and 370C. This instability of CIr was most pronounced at lower ionic strengths and pH 7.6 . At 0C, however, CIr activity was stable for this time over a wide pH range.
The stability of CIr at pH 7.5 and RSC 0.02 was explored at various concentrations of Clr. A highly Step 1: DEAE-cellulose; applied neutral euglobulin from human serum.
Step 2: CM-cellulose; applied CIr pool from step 1.
Step 3: Preparative disc acrylamide electrophoresis of CIr pool from step 2; See text for experimental details.
purified CIr preparation (Fig. 1, post-CM 30 'C for 10 min, cooled at 0C, and 0.1 ml of EAC4 at a concentration of 1.5 X 108 cells/ml was added. After 10 min of incubation at 30'C the cells were washed once with DGVBS++ and resuspended in 0.5 ml DGVBS++. One drop of C2 containing 50 SFU/ml was added, and after 10 min of incubation at 30°C, 2.0 ml of 1/100 C-EDTA was added and the reaction tubes were transferred to the 37°C bath for approximately 15 min. The rate and extent of lysis are proportional to the amount of Cir. As shown in Fig. 1 , the major portion of the Clr activity eluted from 0.150 to 0.180 RSC.
DEAE column fractions containing CIr eluting before the peak of CIs activity were pooled and the pH adjusted to pH 5.0 with 0.2 M acetic acid. (Note that some Cls always eluted with CIr.) The RSC of the pool was adjusted to 0.03 by dilution at 0°C and the diluted sample was applied to a 2.5 X 30 cm CM-cellulose column (CM-23 Whatman)equilibrated with 0.030RSC, pH 5.0, and 0.02 M acetate buffer. The column was washed with 2 volumes of this buffer and a gradient made with 1 liter of 0.10 M NaCI in starting buffer and 0.5 liter of starting buffer was begun, collecting 7 ml fractions. Peak CIr activity eluted at a RSC of 0.085, starting at 0.06 RSC. (Fig. 1 ) With these conditions the main peak of CIs eluted at 0.03 RSC. The fractions were scanned for C Ir activity as described above. Fractions containing C Ir activity were carefully pooled to avoid including those that were contaminated with the protein peak that elutes at 0.095 RSC.
The OD280 of this post CM Clr pool was below 0.005, and the number of Cl SFU/ml of Clr ranged in various runs from 20,000 C! SFU/ml when fresh serum was used as starting material to 400 Cl SFU/ml when outdated blood was used. The CIr pool was concentrated and dialyzed against VBS and stored at -700C.
Further purification of Clr was obtained by preparative disc acrylamide electrophoresis. In this way the contaminating albumin and traces of residual Cls were removed. This is necessary before using these preparations for immunization of rabbits. Antisera have been produced in rabbits and will be described later. Acrylamide gel electrophoresis was carried out for 4 hr at 175 v or 15 hr at 100 v. Gels were sliced in 2 mm segments, eluted with 0.15 M NaCi and the CIr activity was determined after 2-24 hr elution. A correlation of activity with protein stain was obtained by slicing the gels longitudinally before elution. The recovery after 3 days of elution was 30-58% of the total activity applied. As shown in Fig. 1 Fig. 3 , the activity of CIr migrates as a $-globulin. The relative mobility of CIr in relation to albumin was 0.4 at these conditions. The upper and lower portions of the agarose gel containing human serum were developed for 24 hr using the forced diffusion method of van Oss and Bronson (22) to increase the sensitivity. Horse antiserum against human serum was placed in the upper trough, and an antiserum prepared by immunizing the rabbits with highly purified Clr was placed in the lower trough. In the latter case, only one line corresponding with the zone of CIr activity could be demonstrated after 24 hr of diffusion as shown in Fig. 3 . Characterization of this antibody is now in progress. A post-CM preparation of Clr containing 13,300 C! SFU/ml and 0.120 OD280 U/ml did not react with horse anti-human serum. However, it showed one band migrating to the same position as the band seen with human serum when rabbit antiserum against highly purified CIr was placed in the trough. Ouchterlony analysis of this CIr preparation concentrated 10-fold (1.2 OD280 U/ml) yielded three bands against anti-human serum. Faint reactions were observed with anti-Cls and anti-C3, and a strong reaction was obtained with anti-human serum albumin. These proteins represent trace contaminants at that stage of purification and emphasize the need for the final acrylamide step to prepare CIr for use as an antigen.
Sephadex G-200 gel filtration. In order to estimate the molecular weight of Cir, 0.25 ml of crude CIr was applied at 40C to a 1 X 50 cm Sephadex G-200 column equilibrated with VBS without gelatin or metals. 0.65 ml fractions were collected and assayed for Clr activity. The column was calibrated with 1251-labeled human serum albumin and cytochrome c.
Since crude CIr is contaminated with IgG, the elution position of IgG was assayed with a sensitive radial immunodiffusion method and the value was used as an additional protein to calibrate the column. The results are shown in Fig. 4 . Using the method of Andrews (26), the calculated molecular weight of CIr was 168,100.
CIr assay. The formation of macromolecular C! in the fluid phase in the presence of excess amounts of Clq and Cls forms the basis for this hemolytic assay of CIr and in this regard is similar to the method described by Lepow et Fig. 5 show that the optimal time of, incubation is between 30 formed CI molecules were assayed in the same manner described above. The dose-response curve is linear up to 636 C! SFU/ml of CIr at which level it tends to plateau, suggesting a limiting concentration of Clq or Cis at this point. As the number of Clq or Cis molecules in the incubation mixture was more than the number of newly formed C! molecules, an inefficiency of combination with CIr or a multiplicity of Clq or Cls subunits in each Cl molecule is suggested. Direct assay shows that the number of Cis is less than two (27) in an EAC14 site. Alternatively, because Clq is relatively labile antigenically, as noted by Hanauer and Christian (1), and functionally our first thought was that some of the Clq is inactive. Specific activities of Clq preparations require further study. Specific activities of Cis have been determined and are relatively constant (12) .
The dose response of C! formed from purified subunits was determined in another experiment. Our interest was stimulated by the fact that C1 in whole serum does not give a linear dose-response curve using the assay method described by Borsos and Rapp (13) .
On the other hand most of the partially purified C1 preparations give a linear-titration curve, but some require activation. Deviations from linearity have been tentatively interpreted as evidence of a reversible association of subunits and/or activation of at least one from a precursor state (28) . The dose-response behavior of the CI formed -by combination of the three highly purified subunits at different subplateau concentrations of CIr was determined (Fig. 7) . The Clq and Cls concentrations were the same as used in the preceding experiment. Since As expected, the number of C! macromolecules obtained in this last experiment was linearly related to the concentration of Clr (Fig. 8) . This relationship has always been found provided Clr is diluted below the plateau point. The assay method as outlined, in Table III is useful for purification and mechanism studies as it is reproducible and the response is stoichiometrically related to the Clr concentration. DISCUSSION CIr is one of the last complement components to be obtained in a highly purified state. Its purification was handicapped by its instability, low serum concentration, and physicochemical properties similar to many other proteins in human serum. The stability data that we have presented indicate that careful selection of pH, ionic strength, and temperature allow a high degree of purification while preserving the hemolytic activity. The neutral euglobulin preparation described by Tamura and Nelson is a suitable starting material for chromatography since it contains 90-99% of the C1 activity and less than 1% of the serum protein (17) . 99% of the other eight complement components remain in the supernatant phase, although traces of C4, C5, and C3 are known to be contaminants of this euglobulin precipitate (17) .
As CIr is a 3-globulin and most of the complement components as well as many unrelated human serum proteins are also 13-globulins, this first purification step is important because it eliminates a major portion of the serum contaminants.
C3 and C4 can be removed by careful chromatography as suggested by Lepow et al. (7), and Clq is easily separated from Clr due to its markedly different size and charge. The last acrylamide step in the fractionation procedure is necessary to obtain a high degree of purification for immunization. Trace contaminants of C3, Cls, and albumin can be removed readily because of their faster mobility. The acrylamide segments containing CIr may be emulsified with. Freund's adjuvant for immunization. Previously a similar method to obtain monospecific antibody to Cls was used (12) . Characterization of the antisera produced against these CIr preparations is still in process. The antisera give one precipitation line with these highly purified preparations, one line with whole human serum and do not react with serum from patient C. C., known to be functionally deficient in CIr (15) .
Using highly purified CIr, we were able to study some of its physiochemical properties. The molecular weight of Clr determined by Andrews' method is 168,100. This agrees with data of Naff, Pensky, and Lepow (29) showing that the sedimentation of CIr activity in sucrose density gradients corresponded to that of a 7S protein marker. CIr behaved as a 13-globulin in agarose electrophoresis at pH 8.6 in the presence of EDTA. However, if Clq and Cls were added and the electrophoretic run was performed in the presence of Ca++, no Clr activity was found in the ,-'globulin zone.
On the contrary, C1 activity was present at the application point suggesting that reformation of macromolecular C1 had taken place. A similar experiment has been done with Cis and its monospecific antisera (30) .
The electrophoretic mobility of Clr on acrylamide gels was that of a slow 13-globulin and, characteristically, a diffuse pattern was found (Fig. 2) suggesting microheterogeneity.
The hypothesis that CIr may be an enzyme capable of activating Cls from its precursor form to its active form was suggested by Naff and Ratnoff (11 As a quantitative hemolytic assay for Cir is necessary to study these biological questions, we investigated the optimum assay conditions. The hemolytic assay described capitalizes on the fact that macromolecular C! can be assembled from Clq, Clr and Cis, and that the binding of CI to EAC4 is firm at low ionic strength. Consequently all the uncombined reagents can be washed away and titration of the bound CI may be performed by the quantitative method of Borsos and Rapp (13) . Since highly purified Clq and Cls were available and their protein concentration could be measured using radial immunodiffusion, the quantities of Clq and Cls reagents used in the first step (Table  III) of the assay are specified in micrograms. Although the specific activity of the Cis used in these assays is known, our study of the specific activity of Clq is incomplete and is hampered by its greater lability. However, the amounts of Clq and Cls used are in excess as shown by the dose response data as CIr is varied (Fig. 6 ). The number of CI molecules formed when CIr is added at concentrations below saturation or plateau zone is a linear function of the CIr concentration. Although this suggests that there is one CIr subunit in every CI site a more direct study is needed. The concept of a C1 site-forming unit, C1 SFU, is useful to express the CIr titers. A C! SFU is that amount of CIr which when added to optimal amounts of Clq and Cls forms 1.5 X 108 effective molecules of Cl which in the assay represents an average of one effective molecule per cell. As constructed this assay can not be used if the CIr source contains Clq and Cls as would be the case for whole serum. Using antisera and radial immunodiffusion we plan to determine the specific activity of Clr and the serum concentration as was done for Cls (12) . Also it will be important to determine the absolute number of Clq and CIr subunits in a cell bound C! molecule.
The described preparation of Clr will allow us to determine the effect -of CIr on Cls and the precise mechanism by which Cls is activated in diseases such as rheumatoid arthritis (synovial fluid), systemic lupus erythematosus, acute poststreptococcal glomerulonephritis and hereditary angioedema. For instance the clinical and biochemical studies of the latter condition suggest a multiple step phenomenon (6) . Studies by others on activation suggest that the ionic strength and Ca++ concentrations are important (32) . Activation can also occur with proteolytic enzymes not known to be in the complement system, such as plasmin, trypsin, lysosomal enzymes, and Hageman factor (33, 34, 10) . It is interesting that Ca++ has been shown to have a sparing effect on C1 activity. We have preliminary evidence that this effect of Ca++ may be on Clr. When a neutral euglobulin preparation of C1 is incubated in 0.01 M EDTA at low ionic strength, at 300C all the C1 activity is lost. This activity can be restored by adding purified Cir. Furthermore, if the EDTA inactivated C1 is subjected to DEAE-cellulose chromatography CIr activity cannot be detected. More precise information on the role of Ca++ is necessary.
